QUINOVARE Trademark

Trademark Overview

On Thursday, December 26, 2019, a trademark application was filed for QUINOVARE with the United States Patent and Trademark Office. The USPTO has given the QUINOVARE trademark a serial number of 79277818. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 29, 2020. This trademark is owned by Beijing QS Medical Technology Co., Ltd.. The QUINOVARE trademark is filed in the Medical Instrument Products category with the following description:

Needle-based and needle-free injection systems; injection instruments without needles; injection device for pharmaceuticals; medical apparatus, namely, infusion and injection devices for administering drugs
quinovare

General Information

Serial Number79277818
Word MarkQUINOVARE
Filing DateThursday, December 26, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 29, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesNeedle-based and needle-free injection systems; injection instruments without needles; injection device for pharmaceuticals; medical apparatus, namely, infusion and injection devices for administering drugs

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 12, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeijing QS Medical Technology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events

Event DateEvent Description
Tuesday, November 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 29, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 29, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, July 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, July 7, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 7, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, May 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 29, 2020ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, October 29, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 1, 2020REFUSAL PROCESSED BY IB
Monday, April 13, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 13, 2020REFUSAL PROCESSED BY MPU
Friday, March 27, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 26, 2020NON-FINAL ACTION WRITTEN
Friday, March 20, 2020ASSIGNED TO EXAMINER
Tuesday, February 18, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, February 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 11, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 6, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

quinovare injection needle namely apparatus infusion devices drugs administering medical device